BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35014499)

  • 1. Targeted Delivery of Dual Anticancer Drugs Based on Self-Assembled iRGD-Modified Soluble Drug-Polymer Pattern Conjugate Nanoparticles.
    Li C; Chen Z; Zheng D; Zhao J; Lei J
    ACS Appl Bio Mater; 2021 Feb; 4(2):1499-1507. PubMed ID: 35014499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient prodrug-based nanoscale delivery platform constructed by water soluble eight-arm-polyethylene glycol-diosgenin conjugate.
    Li C; Dai J; Zheng D; Zhao J; Tao Y; Lei J; Xi X; Liu J
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():153-160. PubMed ID: 30813015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma.
    Li H; Shi S; Wu M; Shen W; Ren J; Mei Z; Ran H; Wang Z; Tian Y; Gao J; Zhao H
    Int J Nanomedicine; 2021; 16():6455-6475. PubMed ID: 34584411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles.
    Chu Y; Chen N; Yu H; Mu H; He B; Hua H; Wang A; Sun K
    Int J Nanomedicine; 2017; 12():1353-1368. PubMed ID: 28260884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
    Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y
    Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin.
    Pu X; Zhao L; Li J; Song R; Wang Y; Yu K; Hou X; Qiao P; Zong L; Chang S
    Acta Biomater; 2019 Apr; 88():357-369. PubMed ID: 30822554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled targeted folate-conjugated eight-arm-polyethylene glycol-betulinic acid nanoparticles for co-delivery of anticancer drugs.
    Dai L; Cao X; Liu KF; Li CX; Zhang GF; Deng LH; Si CL; He J; Lei JD
    J Mater Chem B; 2015 May; 3(18):3754-3766. PubMed ID: 32262850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
    Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iRGD-mediated core-shell nanoparticles loading carmustine and O
    Liu C; Yao S; Li X; Wang F; Jiang Y
    J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coadministration of iRGD with Multistage Responsive Nanoparticles Enhanced Tumor Targeting and Penetration Abilities for Breast Cancer Therapy.
    Hu C; Yang X; Liu R; Ruan S; Zhou Y; Xiao W; Yu W; Yang C; Gao H
    ACS Appl Mater Interfaces; 2018 Jul; 10(26):22571-22579. PubMed ID: 29878758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
    Hu C; Huang Y; Chen Y
    Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiphilic block polymer-based self-assembly of high payload nanoparticles for efficient combinatorial chemo-photodynamic therapy.
    Ma Q; Zhao Y; Guan Q; Zhao Y; Zhang H; Ding Z; Wang Q; Wu Y; Liu M; Han J
    Drug Deliv; 2020 Nov; 27(1):1656-1666. PubMed ID: 33233958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy.
    Zhang J; Hu J; Chan HF; Skibba M; Liang G; Chen M
    Nanomedicine; 2016 Jul; 12(5):1303-11. PubMed ID: 26964482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the tumor-penetrating peptide internalizing RGD for cancer treatment and diagnosis.
    Qian J; Zhou S; Lin P; Lei J; Zheng S; Xu W; Wang Y; Gao Z; Yang J
    Drug Dev Res; 2023 Jun; 84(4):654-670. PubMed ID: 36959702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.
    Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D
    Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS-Responsive and active targeted drug delivery based on conjugated polymer nanoparticles for synergistic chemo-/photodynamic therapy.
    Zhang Z; Lu Z; Yuan Q; Zhang C; Tang Y
    J Mater Chem B; 2021 Mar; 9(9):2240-2248. PubMed ID: 33596297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer.
    Zhang D; Chu Y; Qian H; Qian L; Shao J; Xu Q; Yu L; Li R; Zhang Q; Wu F; Liu B; Liu Q
    Int J Nanomedicine; 2020; 15():735-747. PubMed ID: 32099362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy.
    Singh T; Kim TW; Murthy ASN; Paul M; Sepay N; Jeong Kong H; Sung Ryu J; Rim Koo N; Yoon S; Song KH; Jun Baek M; Jeon S; Im J
    Eur J Med Chem; 2024 Feb; 265():116050. PubMed ID: 38128233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.